Cargando…
Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450206/ https://www.ncbi.nlm.nih.gov/pubmed/36128214 http://dx.doi.org/10.31138/mjr.33.2.173 |
| _version_ | 1784784475191771136 |
|---|---|
| author | Gasparyan, Armen Yuri Kitas, George D. |
| author_facet | Gasparyan, Armen Yuri Kitas, George D. |
| author_sort | Gasparyan, Armen Yuri |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9450206 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Mediterranean Journal of Rheumatology (MJR) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94502062022-09-19 Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors Gasparyan, Armen Yuri Kitas, George D. Mediterr J Rheumatol Editorial The Mediterranean Journal of Rheumatology (MJR) 2022-06-30 /pmc/articles/PMC9450206/ /pubmed/36128214 http://dx.doi.org/10.31138/mjr.33.2.173 Text en © 2022 The Mediterranean Journal of Rheumatology (MJR) https://creativecommons.org/licenses/by/4.0/This work is licensed under and Creative Commons Attribution-NonCommercial 4.0 International License. |
| spellingShingle | Editorial Gasparyan, Armen Yuri Kitas, George D. Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors |
| title | Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors |
| title_full | Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors |
| title_fullStr | Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors |
| title_full_unstemmed | Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors |
| title_short | Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors |
| title_sort | hyperinflammation due to covid-19 and the targeted use of interleukin-1 inhibitors |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450206/ https://www.ncbi.nlm.nih.gov/pubmed/36128214 http://dx.doi.org/10.31138/mjr.33.2.173 |
| work_keys_str_mv | AT gasparyanarmenyuri hyperinflammationduetocovid19andthetargeteduseofinterleukin1inhibitors AT kitasgeorged hyperinflammationduetocovid19andthetargeteduseofinterleukin1inhibitors |